Christine Dieterich

Title: Christine Dieterich: Innovator in Pharmaceutical Formulations

Introduction

Christine Dieterich is a notable inventor based in Solna, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of chronic ulcers. With a total of 3 patents to her name, her work has the potential to improve the quality of life for many patients suffering from hard-to-heal wounds.

Latest Patents

One of Christine's latest patents focuses on the treatment of chronic ulcers. The invention provides a pharmaceutical formulation that includes LL-37 or a pharmaceutically-acceptable salt thereof, combined with one or more pharmaceutically-acceptable diluents or carrier systems. This formulation is designed for the treatment of chronic ulcer wounds, such as venous leg ulcers or diabetic foot ulcers. The method involves the topical application of the formulation to the ulcer, followed by the application of a dressing. The application ensures that the dose of LL-37 at the wound site remains below about 80 µg per cm² of wound area, and/or below about 26.7 µg per cm² of wound area per day of treatment.

Career Highlights

Throughout her career, Christine has worked with various companies, including Promore Pharma AB and Pergasus AB. Her innovative approaches and dedication to research have positioned her as a key figure in her field.

Collaborations

Christine has collaborated with notable colleagues such as Alvar Grönberg and Margit Mahlapuu. These partnerships have further enhanced her research and development efforts.

Conclusion

Christine Dieterich's contributions to pharmaceutical formulations demonstrate her commitment to advancing medical treatments for chronic wounds. Her innovative patents and collaborations highlight her role as a significant inventor in the field.